NCT03902171

Soberlink Within In-Home Addiction Treatment Program

Outcomes Related to Use of Soberlink Within In-Home Addiction Treatment Program for Individuals With Alcohol Use Disorder

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: In-Home Addiction Treatment Institute, Inc. · Academic / Other
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: —

Summary

The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.

Detailed description

The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and who are enrolled in Aware Recovery Care's In-Home Addiction Treatment program where Care Teams will monitor cloud-based breathalyzer results. Soberlink's cloud-based breathalyzer system will provide data to Care Team if the Client has relapsed or is not compliant with testing through the Soberlink System. Clients will use Soberlink for 180 days within context of routine alcohol use disorder treatment at Aware Recovery Care.

Conditions

• Alcohol Use Disorder

Interventions

Type	Name	Description
DEVICE	Soberlink	Soberlink delivers real-time blood alcohol results to people who support individuals in recovery from alcohol use disorder. In-Home Addiction Treatment program Care Team monitors and responds to results as part of care to improve treatment outcomes.

Timeline

• Start date: 2019-04-02
• Primary completion: 2020-02-28
• Completion: 2020-09-05
• First posted: 2019-04-03
• Last updated: 2019-04-05

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated device study